JP2006511211A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006511211A5 JP2006511211A5 JP2004538747A JP2004538747A JP2006511211A5 JP 2006511211 A5 JP2006511211 A5 JP 2006511211A5 JP 2004538747 A JP2004538747 A JP 2004538747A JP 2004538747 A JP2004538747 A JP 2004538747A JP 2006511211 A5 JP2006511211 A5 JP 2006511211A5
- Authority
- JP
- Japan
- Prior art keywords
- expression construct
- seq
- dna expression
- acid sequence
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10244863 | 2002-09-23 | ||
| PCT/DE2003/003179 WO2004028562A2 (de) | 2002-09-23 | 2003-09-19 | Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006511211A JP2006511211A (ja) | 2006-04-06 |
| JP2006511211A5 true JP2006511211A5 (enExample) | 2006-11-09 |
| JP4411213B2 JP4411213B2 (ja) | 2010-02-10 |
Family
ID=32038184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004538747A Expired - Fee Related JP4411213B2 (ja) | 2002-09-23 | 2003-09-19 | ネコ白血病ウィルスによるネコ感染症のようなオンコウィルス感染症に対するワクチン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7915035B2 (enExample) |
| EP (1) | EP1553977B1 (enExample) |
| JP (1) | JP4411213B2 (enExample) |
| AT (1) | ATE335507T1 (enExample) |
| AU (1) | AU2003281917A1 (enExample) |
| DE (2) | DE10393824D2 (enExample) |
| DK (1) | DK1553977T3 (enExample) |
| ES (1) | ES2270120T3 (enExample) |
| WO (1) | WO2004028562A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0901593D0 (en) * | 2009-01-30 | 2009-03-11 | Touchlight Genetics Ltd | Production of closed linear DNA |
| US20130197612A1 (en) | 2010-02-26 | 2013-08-01 | Jack W. Lasersohn | Electromagnetic Radiation Therapy |
| GB201013153D0 (en) | 2010-08-04 | 2010-09-22 | Touchlight Genetics Ltd | Primer for production of closed linear DNA |
| RS58289B1 (sr) * | 2011-07-20 | 2019-03-29 | Merial Ltd | Rekombinantna vakcina protiv virusa mačje leukemije koja sadrži optimizovani gen omotača virusa mačje leukemije |
| JP7731670B2 (ja) * | 2017-11-06 | 2025-09-01 | インターベット インターナショナル ベー． フェー． | ネコ白血病ウイルスワクチン |
| EP3706788A1 (en) | 2017-11-06 | 2020-09-16 | Intervet International B.V. | Feline leukemia virus vaccine |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU607399B2 (en) * | 1985-09-09 | 1991-03-07 | Cetus Corporation | Infectious recombinant virus vaccine for feline leukemia |
| EP0575491B1 (en) * | 1991-03-07 | 2003-08-13 | Virogenetics Corporation | Genetically engineered vaccine strain |
| FR2751223B1 (fr) * | 1996-07-19 | 1998-12-04 | Rhone Merieux | Formule de vaccin polynucleotidique felin |
| DE19648625A1 (de) * | 1996-11-13 | 1998-05-14 | Soft Gene Gmbh | Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer |
| US6696291B2 (en) * | 1997-02-07 | 2004-02-24 | Merck & Co., Inc. | Synthetic HIV gag genes |
| US6248582B1 (en) * | 1997-10-08 | 2001-06-19 | Imran Khan | Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV |
| SE9803099D0 (sv) * | 1998-09-13 | 1998-09-13 | Karolinska Innovations Ab | Nucleic acid transfer |
| CN1564867B (zh) * | 2001-10-02 | 2010-05-12 | 莫洛根股份公司 | 治疗利什曼原虫感染的dna表达构建体 |
-
2003
- 2003-09-19 WO PCT/DE2003/003179 patent/WO2004028562A2/de not_active Ceased
- 2003-09-19 AT AT03773451T patent/ATE335507T1/de active
- 2003-09-19 DE DE10393824T patent/DE10393824D2/de not_active Expired - Fee Related
- 2003-09-19 AU AU2003281917A patent/AU2003281917A1/en not_active Abandoned
- 2003-09-19 EP EP03773451A patent/EP1553977B1/de not_active Expired - Lifetime
- 2003-09-19 JP JP2004538747A patent/JP4411213B2/ja not_active Expired - Fee Related
- 2003-09-19 DE DE50304603T patent/DE50304603D1/de not_active Expired - Lifetime
- 2003-09-19 DK DK03773451T patent/DK1553977T3/da active
- 2003-09-19 ES ES03773451T patent/ES2270120T3/es not_active Expired - Lifetime
- 2003-09-23 US US10/528,748 patent/US7915035B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20190315642A1 (en) | Compositions for in vivo Expression of Therapeutic Sequences in the Microbiome | |
| JP2023543803A5 (enExample) | ||
| JP3830525B2 (ja) | 組織横断輸送を強化するペプチドとその同定法および使用法 | |
| RU2677799C2 (ru) | Модифицированные суперспиральные белки с улучшенными свойствами | |
| JP2012532601A5 (enExample) | ||
| JP2008529558A5 (enExample) | ||
| JP2004503213A5 (enExample) | ||
| AU2025205053A1 (en) | Compositions including Sbi adjuvants and methods of use thereof | |
| JP2020510426A5 (enExample) | ||
| US20160367701A1 (en) | Compositions for in vivo Expression of Therapeutic Sequences in the Microbiome | |
| JP2004524824A5 (enExample) | ||
| JP2007516696A5 (enExample) | ||
| JP2010512160A5 (enExample) | ||
| JP2002542827A5 (enExample) | ||
| JPH05503945A (ja) | サイトカイン型の活性を有するタンパク質、およびその生産のための組換えｄｎａ、発現ベクターおよび宿主 | |
| CN116782928A (zh) | 能够将抗原递送至mhc-ii途径并在宿主中诱导cd4+和cd8+t细胞应答的慢病毒载体 | |
| CN116209771A (zh) | 用于改善疫苗接种的组合物和方法 | |
| FR2726576A1 (fr) | Production de peptides analogues de peptides hydrophobes, peptide recombinant, sequence d'adn correspondante | |
| JP2024512722A5 (enExample) | ||
| JP2002536418A5 (enExample) | ||
| CN112725378A (zh) | 一种人工改造的akt3环状rna及其在新冠疫苗中的应用 | |
| WO2002068662A8 (en) | Plasmid originated from bifidobacterium, recombinant expression vector using the plasmid and transformation method | |
| WO2015116531A1 (en) | Therapeutic phages and methods for delivery of nucleic acids for therapeutic uses | |
| JP2003334089A5 (enExample) | ||
| JP2024522842A5 (enExample) |